BSE filing, NSE: CHOKSILA. Summary written from the filing by ALFA Finder's alert engine.
Choksi Laboratories Ltd: key numbers
- Share price
- ₹213.95
- Market cap
- ₹149.0 Cr
- Revenue (annual)
- ₹46.01 Cr
- Net profit (annual)
- ₹1.96 Cr
- P/E (TTM)
- 68.9×Sector 52.0×
- Promoter holding
- 31.48%+0.00% QoQ
- FII holding
- 10.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Choksi Laboratories Ltd
All →Choksi Laboratories Convertible Warrants
Choksi Laboratories' proposed convertible warrants issue was rejected at its EGM on October 17, 2026. The company requests BSE to close the in-principle approval application.
Choksi Laboratories Convertible Warrants
Choksi Laboratories' EGM on 17 Oct 2026 rejected the special resolution to allot convertible warrants to promoters. 99.46% of votes polled were against, blocking the capital raise.
Choksi Laboratories Convertible Warrants
Choksi Laboratories held an EGM regarding the issuance of convertible warrants on a preferential basis. The promoters and proposed allottees abstained from voting on the resolution.
Choksi Laboratories Other Announcement
Choksi Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Choksi Laboratories Annual General Meeting
Choksi Laboratories Ltd has scheduled an EGM for October 17, 2026, to seek shareholder approval for issuing 3.50 lakh convertible warrants at ₹177 per warrant.
- Value
- ₹6.20 Cr
Choksi Laboratories Capital Structure Change
Choksi Laboratories board approved a preferential issue of 3.5 lakh warrants to promoters at Rs 177 per warrant, totaling Rs 6.195 Crore.
- Value
- ₹6.20 Cr
Other annual general meeting announcements
All →Tasty Bite Eatables Annual General Meeting
Tasty Bite Eatables declared postal ballot results approving a material related-party transaction with Mars Food UK Limited for purchase of a capital asset. Promoter group did not vote and the resolution passed with 99.99% of votes cast in favour.
Unihealth Hospitals Annual General Meeting
Unihealth Hospitals reported postal ballot results: all three resolutions passed, covering a related-party loan-to-equity conversion with UMC Hospitals, variation of unutilised IPO proceeds, and migration from NSE Emerge to the main board. No rupee amount is stated for the approvals.
Vedanta Iron and Steel Annual General Meeting
Vedanta Iron and Steel seeks shareholder approval via postal ballot for seven material related party transaction resolutions. E-voting runs from 29 October to 27 November 2026.
GTPL Hathway Annual General Meeting
GTPL Hathway seeks shareholder approval by postal ballot to appoint Gurjeev Singh Kapoor as Non-Executive Director. E-voting runs November 1 to 30, 2026.
HEG Advanced Materials Annual General Meeting
HEG Advanced Materials seeks approval via postal ballot to appoint seven directors and fix MD Riju Jhunjhunwala's remuneration. E-voting runs October 29 to November 27, 2026.
Trident Texofab Annual General Meeting
Trident Texofab's EGM on 28 October 2026 sought approval for a statutory auditor to fill a casual vacancy. Only one ordinary resolution was tabled.